Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma

NCT02297958 · clinicaltrials.gov ↗
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Rennes University Hospital